+ Follow
Photo by Pixabay: www.pexels.com/
In 2020, a popular heartburn medication called Ranitidine, manufactured in India, was recalled globally due to the presence of a potentially cancer-causing contaminant called N-Nitrosodimethylamine (NDMA).

India is often called the "pharmacy of the world," supplying life-saving medicines to millions. But beneath this shiny exterior lies a troubling truth.

Recent years have seen a rise in medicine recalls, concerns about quality control, and even deaths linked to exported drugs. This isn't just about statistics; it's about your health, your family's health, and the future of our nation.

A Shadow Over "The Pharmacy of the World"

Medicine recalls are a harsh reality, but their frequency in India is alarming.

In May 2021, during the COVID-19 pandemic’s second wave in India, a batch of Remdesivir manufactured by Zydus Cadila was linked to adverse events in patients across several states in India.

Patients who received this batch of the antiviral drug experienced symptoms like fever, chills, and a dramatic drop in blood oxygen levels.

The issue was identified and the use of Cadila’s Remdesivir was discontinued, leading to an improvement in the patient’s condition.

This incident highlighted the need for stringent quality control in the production of such critical medications.

In 2022, the world watched in horror as Maiden Pharmaceuticals' cough syrup was linked to the deaths of 66 children in Gambia. This wasn't a mere accident.

The syrup, also exported to other countries, contained lethal amounts of diethylene glycol – a chemical used in antifreeze, not medicine.

The Maiden case wasn't an isolated incident. In 2020, the US Food and Drug Administration (USFDA) banned imports from several Indian drug manufacturers due to quality control.

If foreign authorities are banning these medicines, why are we, in India, willing to sell them for quick bucks? Is the short-term financial gain worth the potential long-term health risks for ourselves and our children?

The Murky World of Medical Representatives (MRs)

MRs visit doctors’ clinics to present information about their companies’ drugs. While many operate ethically, some might downplay potential side effects or selectively present information to convince doctors to prescribe their specific brands.

Some doctors might perceive certain marketing practices as normal, potentially hindering their ability to critically evaluate the information presented by MRs.

The Whistleblowers:

Whistleblowers have played a significant role in exposing malpractices in the Indian pharmaceutical industry. 

Narayan Konduru Reddy, a former employee of GVK Biosciences, became a prominent whistleblower when he reported the data manipulation at the company, leading to a ban on 700 drugs tested by GVK across the European Union.

Another notable figure is Dinesh Thakur, who exposed quality issues at Ranbaxy and has since been advocating for better regulation of medicines in India.

However, the climate of fear discourages whistleblowing and hinders efforts to improve drug safety. People who tell the truth about problems in the medicine-making industry often face big challenges. They can lose their jobs, be ignored, and fight long, hard legal battles.

In India, it’s even tougher because the laws can punish them and the regulatory authorities tasked with overseeing pharmaceutical companies do not always fulfill their responsibilities effectively.

India's Whistleblower Protection Act 2014 offers legal safeguards for those who speak out.

Strengthening whistleblower protection laws is crucial. We also need robust support systems for them, like anonymous reporting channels and independent legal aid.

How you can take Charge of Your Health?

1. Talk to Your Doctor, Ask Questions! Don't hesitate to inquire about the origin and quality of the medicines they prescribe. A good doctor will welcome your questions and provide the information you need to make informed choices about your health.

2. Be Cautious of Brand Loyalty: Doctors may recommend certain brands due to familiarity or positive experiences. While brand loyalty can be helpful, be wary of doctors who excessively glorify specific brands, especially if it seems linked to incentives.

3. Become a Medicine Detective: Technology empowers you! The Central Drugs Standard Control Organization (CDSCO) website lists medicine recalls and details about companies facing quality control issues. Use this information to your advantage.

4. Research and Learn From Reliable Sources: Several YouTubers and online platforms dedicate themselves to researching and disseminating accurate information about the pharmaceutical industry. Look for channels with a strong reputation for unbiased, evidence-based content.

5. Citizen Science: Several Apps or online platforms are available where citizens can report suspicious drug activity or share information about medicine recalls to create a sense of community and empower individuals to take action.

Imagine being able to scan a medication barcode with your phone and access information about its safety and potential recalls. Citizen science initiatives can be a game-changer in this regard.

A Call to Action: Strengthening the System

The responsibility to ensure the safety of medications in India doesn't fall on one entity alone. Here's how different players can contribute to a more robust system:

1. The Government's Role:

• Crackdown on lax practices: The Central Drugs Standard Control Organization (CDSCO) needs a serious upgrade. Increased resources and staff are essential for conducting regular, thorough inspections of pharmaceutical production facilities. This will prioritize quality control.

• Protecting the Whistleblowers: Employees who speak out about safety violations are heroes, not villains. Strong whistleblower protection laws, like the existing Whistleblower Protection Act 2014, are crucial. But enforcement is equally important.

We need to see these laws used effectively to shield brave individuals who come forward.

• Swift Investigations: A dedicated system for swift and impartial investigations into allegations of unethical practices is vital. This discourages companies from brushing concerns under the rug and ensures a swift response to potential dangers.

2. The Media's Watchdog Role:

Newspapers and television channels have a powerful voice. They must hold the industry accountable by:

• Investigative Journalism: Expose unethical practices through in-depth investigations. Don't succumb to pressure from pharmaceutical giants who may be advertisers.

• Supporting Whistleblowers: Give whistleblowers a platform to share their stories. This empowers others to speak up and shines a light on potential wrongdoing.

This isn't about a blame game. It's about creating a culture of transparency and accountability. It's about ensuring the medicines we rely on are truly life-saving.

Together, we can make a difference. Patients, doctors, pharmaceutical employees, whistleblowers, the media, and the government – all have a role to play. By working together, we can ensure India lives up to its title as the "pharmacy of the world," a place where quality and safety are paramount.

References:

.    .    .

Discus